Treatment Agreements Do Not Change Clinicians' Permissive Attitudes of Cannabis Use Among Patients on Long-Term Opioid Therapy.
作者信息
Fried Martin, Joshi Shivam, Thomas Nicole, Richards Nathan, Svirsky Larisa, Zettler Patricia J, Howard Dana
机构信息
Division of General Internal Medicine, Ohio State University College of Medicine, Columbus, OH, USA.
Center for Biostatistics, Ohio State University Wexner Medical Center, Columbus, OH, USA.
出版信息
J Gen Intern Med. 2025 May;40(7):1687-1689. doi: 10.1007/s11606-024-09206-7. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Treatment Agreements Do Not Change Clinicians' Permissive Attitudes of Cannabis Use Among Patients on Long-Term Opioid Therapy.治疗协议并未改变临床医生对长期接受阿片类药物治疗患者使用大麻的宽容态度。
J Gen Intern Med. 2025 May;40(7):1687-1689. doi: 10.1007/s11606-024-09206-7. Epub 2024 Nov 25.
2
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence Treatment.临床医生对接受阿片类药物依赖治疗的患者使用大麻及大麻治疗的看法。
Drug Alcohol Rev. 2025 Jul;44(5):1339-1350. doi: 10.1111/dar.14074. Epub 2025 May 5.
3
The Legal Landscape for Opioid Treatment Agreements.阿片类药物治疗协议的法律背景。
Milbank Q. 2024 Sep;102(3):632-668. doi: 10.1111/1468-0009.12699. Epub 2024 May 10.
4
A Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.美国的实用主义、以人为本的大麻观：追求超越信仰的关怀。
Subst Abus. 2023 Oct;44(4):337-347. doi: 10.1177/08897077231202836. Epub 2023 Oct 30.
5
Effects of randomization to buprenorphine or naltrexone for OUD on cannabis use outcomes: A secondary analysis of the X:BOT trial.随机分配使用丁丙诺啡或纳曲酮治疗阿片类物质使用障碍对大麻使用结果的影响：X:BOT试验的二次分析。
Drug Alcohol Depend. 2025 Mar 1;268:112550. doi: 10.1016/j.drugalcdep.2025.112550. Epub 2025 Jan 18.
6
Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence.剔除真相：大麻使用向阿片类药物使用和阿片类药物使用障碍、滥用或依赖的转变的系统评价和荟萃分析。
Addiction. 2022 Feb;117(2):284-298. doi: 10.1111/add.15581. Epub 2021 Jul 15.
7
Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study.患者和临床医生在阿片类药物使用障碍治疗中对面对面、视频和电话模式的体验：一项定性研究。
J Gen Intern Med. 2024 Sep;39(12):2179-2186. doi: 10.1007/s11606-023-08586-6. Epub 2024 Jan 16.
9
Cannabidiol in the context of substance use disorder treatment: A systematic review.大麻二酚治疗物质使用障碍：系统评价。
Addict Behav. 2022 Sep;132:107360. doi: 10.1016/j.addbeh.2022.107360. Epub 2022 May 7.
10
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
本文引用的文献
1
Redesigning Opioid Pain Agreements to Promote Patient-Centered Care.重新设计阿片类药物疼痛治疗协议以促进以患者为中心的护理。
JAMA Intern Med. 2023 Mar 1;183(3):179-180. doi: 10.1001/jamainternmed.2022.6520.
2
Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.长期和严重的医用大麻和大麻素对慢性疼痛的危害：非随机研究的系统评价。
BMJ Open. 2022 Aug 4;12(8):e054282. doi: 10.1136/bmjopen-2021-054282.
3
Physicians' experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review.医生对医用大麻的经验、态度和信念：系统文献综述。
BMC Fam Pract. 2021 Oct 21;22(1):212. doi: 10.1186/s12875-021-01559-w.
4
Breaking the pain contract: A better controlled-substance agreement for patients on chronic opioid therapy.打破疼痛契约：为慢性阿片类药物治疗患者制定更好的受控物质协议。
Cleve Clin J Med. 2016 Nov;83(11):827-835. doi: 10.3949/ccjm.83a.15172.
5
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates.退伍军人健康管理局关于大麻作为阿片类药物疼痛治疗辅助手段的政策。
AMA J Ethics. 2015 Jun 1;17(6):558-61. doi: 10.1001/journalofethics.2015.17.6.pfor2-1506.
Zotero 插件